Freedman Financial Associates, Inc. Johnson & Johnson Transaction History

Freedman Financial Associates, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$168.19 - $186.01 $462,690 - $511,713	-2,751 Closed	0 $0
Q1 2022 Apr 13, 2022	BUY	$158.14 - $179.59 $7,116 - $8,081	45 Added 1.66%	2,751 $485,000
Q4 2021 Jan 14, 2022	SELL	$155.93 - $173.01 $17,620 - $19,550	-113 Reduced 4.01%	2,706 $463,000
Q3 2021 Oct 08, 2021	BUY	$161.5 - $179.47 $18,734 - $20,818	116 Added 4.29%	2,819 $455,000
Q2 2021 Jul 13, 2021	BUY	$159.48 - $171.07 $5,103 - $5,474	32 Added 1.2%	2,703 $445,000
Q1 2021 May 17, 2021	BUY	$153.07 - $170.48 $306 - $340	2 Added 0.07%	2,671 $439,000
Q4 2020 Feb 17, 2021	BUY	$137.11 - $157.38 $365,946 - $420,047	2,669 New	2,669 $420,000

4,271

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Freedman Financial Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Freedman Financial Associates, Inc. with notifications on news.